Hong Kong-listed medical aesthetics concept stocks fluctuated and strengthened, with Mao Geping (01318.HK) rising more than 10.5%, 3SBio (01530.HK) rising more than 4%, Fosun Pharma (02196.HK) rising more than 3%, and Giant Biotech (02367.HK) and Haohai Biological Technology (06826.HK) both rising more than 2%.